Gönül Veliçelebi

6.2k total citations · 2 hit papers
41 papers, 4.9k citations indexed

About

Gönül Veliçelebi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Gönül Veliçelebi has authored 41 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 26 papers in Cellular and Molecular Neuroscience and 5 papers in Physiology. Recurrent topics in Gönül Veliçelebi's work include Neuroscience and Neuropharmacology Research (19 papers), Receptor Mechanisms and Signaling (13 papers) and Ion channel regulation and function (11 papers). Gönül Veliçelebi is often cited by papers focused on Neuroscience and Neuropharmacology Research (19 papers), Receptor Mechanisms and Signaling (13 papers) and Ion channel regulation and function (11 papers). Gönül Veliçelebi collaborates with scholars based in United States, Switzerland and Australia. Gönül Veliçelebi's co-authors include Michael M. Harpold, Kenneth A. Stauderman, S.B. Ellis, Steven L. Wagner, Jack Roos, J. Ashot Kozak, Maria Lioudyno, Shenyuan Zhang, Kari L. Ohlsen and Michael D. Cahalan and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Gönül Veliçelebi

41 papers receiving 4.7k citations

Hit Papers

STIM1, an essential and c... 1999 2026 2008 2017 2005 1999 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. STIM1, an essential and conserved component of store-operated Ca2 + channel function
    2005 1.5k citations Jack Roos, Paul J. DiGregorio et al. The Journal of Cell Biology profile →
  2. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist
    1999 628 citations Peter J. Flor, Hans Allgeier et al. Neuropharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gönül Veliçelebi United States 24 3.3k 2.5k 1.3k 458 295 41 4.9k
Grigory Krapivinsky United States 29 4.2k 1.3× 2.3k 0.9× 1.3k 1.0× 444 1.0× 1.0k 3.5× 37 6.3k
Jayhong A. Chong United States 13 2.0k 0.6× 1.5k 0.6× 1.7k 1.3× 987 2.2× 194 0.7× 14 4.6k
Kenneth A. Stauderman United States 32 3.3k 1.0× 2.4k 1.0× 3.3k 2.6× 822 1.8× 311 1.1× 62 6.2k
I. Scott Ramsey United States 15 1.9k 0.6× 1.3k 0.5× 1.9k 1.5× 455 1.0× 353 1.2× 21 4.1k
Stephan Philipp Germany 40 3.0k 0.9× 1.6k 0.6× 3.3k 2.6× 952 2.1× 331 1.1× 87 6.2k
Carsten Strübing Germany 19 1.7k 0.5× 1.2k 0.5× 1.8k 1.4× 293 0.6× 196 0.7× 24 3.1k
Alexander I. Sobolevsky United States 39 3.4k 1.0× 2.9k 1.2× 1.1k 0.9× 251 0.5× 105 0.4× 89 5.1k
Kirill Kiselyov United States 38 2.2k 0.7× 1.1k 0.4× 2.0k 1.6× 675 1.5× 143 0.5× 84 5.0k
Andreas Lückhoff Germany 35 2.4k 0.7× 1.2k 0.5× 2.2k 1.7× 926 2.0× 816 2.8× 79 4.9k
Jie Zheng United States 35 1.6k 0.5× 1.1k 0.4× 1.7k 1.4× 567 1.2× 316 1.1× 107 3.6k

Countries citing papers authored by Gönül Veliçelebi

Since Specialization
Citations

This map shows the geographic impact of Gönül Veliçelebi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gönül Veliçelebi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gönül Veliçelebi more than expected).

Fields of papers citing papers by Gönül Veliçelebi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gönül Veliçelebi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gönül Veliçelebi. The network helps show where Gönül Veliçelebi may publish in the future.

Co-authorship network of co-authors of Gönül Veliçelebi

This figure shows the co-authorship network connecting the top 25 collaborators of Gönül Veliçelebi. A scholar is included among the top collaborators of Gönül Veliçelebi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gönül Veliçelebi. Gönül Veliçelebi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grigoryev, Sergey, et al.. (2012). CM3457, a potent and selective oral CRAC channel inhibitor, suppresses T and mast cell function and is efficacious in rat models of arthritis and asthma (72.3). The Journal of Immunology. 188(1_Supplement). 72.3–72.3. 11 indexed citations
2.
Roos, Jack, Paul J. DiGregorio, Andriy V. Yeromin, et al.. (2005). STIM1, an essential and conserved component of store-operated Ca2 + channel function. The Journal of Cell Biology. 169(3). 435–445. 1506 indexed citations breakdown →
3.
Bertram, Lars, Mikko Hiltunen, Michele Parkinson, et al.. (2005). Family-Based Association between Alzheimer's Disease and Variants inUBQLN1. New England Journal of Medicine. 352(9). 884–894. 184 indexed citations
4.
Dykens, James A., et al.. (2002). High-throughput assessment of mitochondrial membrane potential in situ using fluorescence resonance energy transfer. Mitochondrion. 1(5). 461–473. 13 indexed citations
5.
Veliçelebi, Gönül, Kenneth A. Stauderman, Mark A. Varney, et al.. (1999). [2] Fluorescence techniques for measuring ion channel activity. Methods in enzymology on CD-ROM/Methods in enzymology. 294. 20–47. 23 indexed citations
6.
Varney, Mark A., Nicholas D. P. Cosford, Christine Jachec, et al.. (1999). SIB-1757 and SIB-1893: Selective, Noncompetitive Antagonists of Metabotropic Glutamate Receptor Type 5. Journal of Pharmacology and Experimental Therapeutics. 290(1). 170–181. 151 indexed citations
7.
Lloyd, G. Kenneth, Frédérique Menzaghi, Bruno Bontempi, et al.. (1998). The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents. Life Sciences. 62(17-18). 1601–1606. 51 indexed citations
8.
Varney, Mark A., Sara Rao, Christine Jachec, et al.. (1998). Pharmacological Characterization of the Human Ionotropic Glutamate Receptor Subtype GluR3 Stably Expressed in Mammalian Cells. Journal of Pharmacology and Experimental Therapeutics. 285(1). 358–370. 17 indexed citations
9.
Kosinski, Christoph M., David G. Standaert, Timothy J. Counihan, et al.. (1998). Expression of N‐Methyl‐D‐Aspartate receptor subunit mRNAs in the human brain: Striatum and globus pallidus. The Journal of Comparative Neurology. 390(1). 63–74. 2 indexed citations
10.
Daggett, Lorrie P., Edwin C. Johnson, Mark A. Varney, et al.. (1998). The Human N‐Methyl‐d‐Aspartate Receptor 2C Subunit: Genomic Analysis, Distribution in Human Brain, and Functional Expression. Journal of Neurochemistry. 71(5). 1953–1968. 22 indexed citations
11.
Lin, Fen‐Fen, Mark A. Varney, Aida Sacaan, et al.. (1997). Cloning and stable expression of the mGluR1b subtype of human metabotropic receptors and pharmacological comparison with the mGluR5a subtype. Neuropharmacology. 36(7). 917–931. 42 indexed citations
12.
Hess, Stephen D., Lorrie P. Daggett, James H. Crona, et al.. (1996). Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.. Journal of Pharmacology and Experimental Therapeutics. 278(2). 808–816. 62 indexed citations
13.
Provow, Sally & Gönül Veliçelebi. (1990). Limited proteolysis of the vasoactive intestinal peptide receptor: comparison of its folded structure in the membrane-bound and detergent-solubilized states. Regulatory Peptides. 28(1). 71–82. 2 indexed citations
14.
Musso, Gary F., et al.. (1988). Development of helix-based vasoactive intestinal peptide analogues: identification of residues required for receptor interaction. Biochemistry. 27(21). 8174–8181. 18 indexed citations
15.
Veliçelebi, Gönül, et al.. (1988). Structural Characterization of Vasoactive Intestinal Peptide Receptors from Rat Lung Membranes. Annals of the New York Academy of Sciences. 527(1). 266–281. 6 indexed citations
16.
17.
Provow, Sally & Gönül Veliçelebi. (1987). Characterization and Solubilization of Vasoactive Intestinal Peptide Receptors from Rat Lung Membranes. Endocrinology. 120(6). 2442–2452. 26 indexed citations
18.
Veliçelebi, Gönül, Saraswathi Patthi, Sally Provow, & M. Akong. (1986). Covalent Cross-Linking of Growth Hormone-Releasing Factor to Pituitary Receptors. Endocrinology. 118(4). 1278–1283. 18 indexed citations
19.
Veliçelebi, Gönül, Saraswathi Patthi, & E. T. Kaiser. (1986). Design and biological activity of analogs of growth hormone releasing factor with potential amphiphilic helical carboxyl termini.. Proceedings of the National Academy of Sciences. 83(15). 5397–5399. 21 indexed citations
20.
Veliçelebi, Gönül, et al.. (1985). Specific binding of synthetic human pancreatic growth hormone releasing factor (1–40-OH) to bovine anterior pituitaries. Biochemical and Biophysical Research Communications. 126(1). 33–39. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Grigory Krapivinsky Breakdown of academic impact, for papers by Jayhong A. Chong Breakdown of academic impact, for papers by Kenneth A. Stauderman Breakdown of academic impact, for papers by I. Scott Ramsey Breakdown of academic impact, for papers by Stephan Philipp Breakdown of academic impact, for papers by Carsten Strübing Breakdown of academic impact, for papers by Alexander I. Sobolevsky Breakdown of academic impact, for papers by Kirill Kiselyov Breakdown of academic impact, for papers by Andreas Lückhoff Breakdown of academic impact, for papers by Jie Zheng
Rankless by CCL
2026